| |
For an overview, see marketing
fundamentals (HIPAA); for a more detailed treatment of the subject,
see the glossary entry on marketing
(HIPAA).
Note that Better Samaritan
Hospital (BSH) and Big State University (BSU) are fictional organizations.
Any resemblance to existing institutions is purely coincidental.
Patients
regularly ask the staff at Better Samaritan Hospital about the providers
in the BSH preferred provider network, about benefits coverage under
alternative plans, and the like. Is providing this sort of information
considered marketing under HIPAA?
|
Physicians
at Better Samaritan, like those everywhere else, are routinely asked
about alternative treatments for conditions -- such as drugs that
their patients have seen in advertisements on TV or in the newspaper.
Is the discussion of such options marketing?
|
Some
physicians at Better Samaritan Hospital receive remuneration from
pharmaceutical companies for prescribing the latters' most profitable
drugs. Does this sort of practice require a marketing authorization
or a disclosure of the payment arrangement to the patient?
|
Better
Samaritan plans to sell lists of its patients to pharmaceutical
companies, so that the latter can directly market particular drugs
to its patients with particular diagnoses. Does this practice require
a marketing authorization?
|
Better
Samaritan is considering launching a series of newsletters and other
communications, such as mailings reminding women to get an annual
mammogram, providing information about how to lower cholesterol,
about new developments in health care (e.g., new diagnostic tools),
about health or "wellness" classes, about support groups,
and so forth. Does it need an authorization for this?
|
last
modified:
16-Feb-2003
[RC] |